Director Dealing

RNS Number : 0902Z

Physiomics PLC

12 December 2017

 

12^th December 2017

Physiomics plc

("Physiomics") or ("the Company")

Director Dealing

The Company announces that it received notice today that the following Directors sold the following number of ordinary shares in the Company at the following prices per share:

Director	Number of shares sold	Sale price per share
Dr J Millen, CEO	240,000	8.3p
Dr C Chassagnole, COO	600,000	8.3p

Following the sales of shares, the total holdings of each Director of the Company will be as follows:

Dr Paul Harper                   525,707

Dr Jim Millen                     444,641

Dr Christophe Chassagnole   417,008

The total number of shares in issue remains 58,785,394 Ordinary Shares with voting rights attached (one vote per Share).  There are no Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Physiomics under the Disclosure and Transparency Rules.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	James Millen
2	Reason for the notification
a)	Position/status	Director, CEO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Physiomics plc
b)	LEI	213800A71DSZ6ABMTQ91
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary share GB00BDR6W943
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 8.3p 240,000
d)	Aggregated information -     Aggregated volume -     Price	240,000 At 8.3p per share
e)	Date of the transaction	12-12-2017
f)	Place of the transaction	XLON, AIM

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Christophe Chassagnole
2	Reason for the notification
a)	Position/status	Director, COO
b)	Initial notification/ Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Physiomics plc
b)	LEI	213800A71DSZ6ABMTQ91
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary share GB00BDR6W943
b)	Nature of the transaction	Disposal of shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 8.3p 600,000
d)	Aggregated information -     Aggregated volume -     Price	600,000 At 8.3p
e)	Date of the transaction	12-12-2017
f)	Place of the transaction	XLON, AIM

Enquiries:

Physiomics plc                                                  

Dr Jim Millen, CEO

[phone]

WH Ireland Limited (nomad)

Katy Mitchell, James Sinclair-Ford

[phone]

Hybridan LLP (broker)

Claire Louise Noyce

[phone]

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

END

 

 

DSHTTBMTMBBBBIR